Julia Wykrota

Ms. Julia Wykrota


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
EMEmilia Majsiak
Emilia Majsiak
MCMagdalena Choina
Magdalena Choina
IKIzabela Knyziak-Mędrzycka
Izabela Knyziak-Mędrzycka
Joanna Beata BierłaJoanna Beata Bierła
Joanna Beata Bierła
KJKamil Janeczek
Kamil Janeczek
BCBożena Cukrowska
Bożena Cukrowska
In order to answer the question if an IgE-mediated allergy (A-IgE) may occur in subjects with celiac disease (CD), a systematic review was performed of available publications collected in the United States National Institute for Biotechnology Information/National Institutes of Health/National Library of Medicine/PubMed database up to 28 December 2022, with the use of the following keywords “allergy&celiac/coeliac”, “sensitization&celiac/coeliac”, and “anaphylaxis&celiac/coeliac” compared in the form of a conjunction. In total, the search returned 2013 publications from these keywords in any section of the article. As numerous review articles included the above-mentioned entries in the abstract, we decided to focus on the publications with the entries only in the title (n = 63). After rejecting studies unrelated to the topic, narrative reviews, book chapters, conference abstracts, symposium reports, letters to the editor, or non-English articles, 18 publications (6 observational original studies and 12 case reports describing a total of 15 cases of A-IgE developed after a diagnosis of CD) were included to this review. Our study is the first systematic review on allergy occurrence in CD patients. The analysis indicated that the possibility of a coexistence of A-IgE with any food and inhalant allergens in subjects diagnosed with CD should be considered. A sensitization to wheat was the most frequently described in subjects with CD. The clinical manifestation of A-IgE in CD was similar to that in subjects without CD; e.g., with possible atopic dermatitis, vomiting, urticaria, angioedema, or anaphylactic shock. Screening for allergies in subjects with CD should be considered, especially in those cases where symptoms persist after introducing a gluten-free diet. The elimination of wheat from the diet of patients with CD may lead to a loss of immune tolerance and to the development of sensitization, which may even manifest as anaphylaxis. In conclusion, although there are few studies assessing the occurrence of A-IgE in subjects with CD, they show the possibility of a coexistence of both diseases and the high clinical significance of this phenomenon, which indicates the need for further studies.

Verified
Journal Article
Open access
PDF file
BBBarbara Bralewska
Barbara Bralewska
JWJulia Wykrota
Julia Wykrota
Małgorzata KurpesaMałgorzata Kurpesa
Małgorzata Kurpesa
Jaroslaw Damian KasprzakJaroslaw Damian Kasprzak
Jaroslaw Damian Kasprzak
UCUrszula Cieślik-Guerra
Urszula Cieślik-Guerra
Tomasz RechcińskiTomasz Rechciński
Tomasz Rechciński
Introduction: During the COVID-19 pandemic, the availability of cardiac rehabilitation (CR) was limited. On the other hand, during that period of epidemic restrictions, patients with acute coronary syndrome (ACS) required careful control and monitoring after coronary events. The aim of this study was to assess whether CR conducted during the epidemic restrictions in a remote mode ensured similar improvement in physical performance as CR conducted in a centre-based mode before the COVID-19 pandemic. Material and Methods: In this one-centre study, we compared the demographic and clinical profiles of patients after ACS who completed inpatient CR before the COVID-19 era with those of patients who completed telerehabilitation during the COVID-19 pandemic. We assessed the workload on the initial and final exercise tests (ExT) obtained by patients and compared the values of the differences between the final and initial ExT. The study included 359 patients (pts) participating in inpatient CR before October 2020 (the suspension of centre-based CR) and 60 pts who took part in telerehabilitation after July 2021 (the introduction of the tele-CR programme). Both inpatient and tele-CR were performed according to the guidelines of the Working Group for Cardiac Rehabilitation of the National Cardiac Society. A telemedic platform was used to control ECG, blood pressure and body mass of the pts participating in telerehabilitation. Results: The improvement of physical performance did not differ significantly between the two groups. The pts who completed telerehabilitation were significantly older than those who completed inpatient CR. The values of other parameters, such as the percentage of females, BMI, the percentage of pts with arterial hypertension and type 2 diabetes mellitus, as well as left ventricular ejection fraction did not differ significantly between the compared groups. Nor did the results of initial ExT expressed in METs, the results of final ExT and the improvement of workload understood as the difference between the final and initial results of ExT differ significantly—they were 7.7 ± 3.06 vs. 7.89 ± 2.98 with p = 0.82; 9.08 ± 0.29 vs. 8.98 ± 3.48 with p = 0.84, and 1 [0–2.2] vs. 1.2 [0–1.8] with p = 0.17, respectively. Conclusions: In our centre, telerehabilitation after acute coronary syndrome guaranteed an equally good improvement in physical capacity as that observed in inpatient CR patients, regardless of the difference in the age profile of the compared groups. These results encourage the popularization of telerehabilitation with remote monitoring of ECG, blood pressure and body mass.

21 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
BBBarbara Bralewska
Barbara Bralewska
JWJulia Wykrota
Julia Wykrota
Małgorzata KurpesaMałgorzata Kurpesa
Małgorzata Kurpesa
Jaroslaw Damian KasprzakJaroslaw Damian Kasprzak
Jaroslaw Damian Kasprzak
UCUrszula Cieślik-Guerra
Urszula Cieślik-Guerra
Tomasz RechcińskiTomasz Rechciński
Tomasz Rechciński
During the COVID-19 pandemic, the availability of cardiac rehabilitation (CR) was lim-ited. On the other hand, during that period of epidemic hazard, patients after acute cor-onary syndromes (ACS) required careful control and ensuring their improvement after the coronary event. The aim of this study was to assess whether CR conducted during the epidemic threat in a remote mode ensured similar improvement in physical per-formance as CR conducted in a centre-based mode before the COVID-19 pandemic. Material and methods: In this one-centre study, we compared the demographic and clinical profiles of patients after ACS who completed inpatient CR before the COVID-19 era with those of patients who completed telerehabilitation during the COVID-19 pan-demic. We assessed the workload on the initial and final exercise tests (ExT) obtained by patients and compared the values of the differences between the final and initial ExT. The study included 359 patients (pts) participating in inpatient CR before October 2020 (the suspension of centre-based CR) and 60 pts who took part in telerehabilitation after July 2021 (the introduction of the tele-CR programme). Both inpatient and tele- CR were performed according to the guidelines of the Working Group for Cardiac Rehabil-itation of the National Cardiac Society. A telemedic platform was used to control ECG, blood pressure and body mass of the pts participating in telerehabilitation. Statistical analysis included the Mann-Whitney U test, Student’s t-test and chi-square test. Results: The improvement of physical performance did not differ significantly between the two groups. The pts who completed telerehabilitation were significantly older than those who completed inpatient CR. The values of other parameters, such as the percentage of females, BMI, the percentage of pts with arterial hypertension and type 2 diabetes mellitus, as well as left ventricular ejection fraction did not differ significantly between the compared groups. Nor did the results of initial ExT expressed in METs, the results of final ExT and the improvement of workload understood as the difference between the final and initial results of ExT differ significantly – they were 7,7±3,06 vs 7,89±2,98 with p=0,82; 9,08±,29 vs 8,98±3,48 with p=0,84, and 1[0-2,2] vs 1,2[0-1,8] with p=0,17, respec-tively. Conclusions: In our centre, telerehabilitation after acute coronary syndrome guaranteed an equally good improvement in physical capacity as that observed in inpatient CR pa-tients, regardless of the difference in the age profile of the compared groups. These re-sults encourage the popularization of the cardiac rehabilitation mode with the remote monitoring of the ECG, blood pressure and body mass.

27 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JGJakub Grandos
Jakub Grandos
MŁMateusz Łaszczych
Mateusz Łaszczych
JNJulia Nowak
Julia Nowak
BBBarbara Bralewska
Barbara Bralewska
JWJulia Wykrota
Julia Wykrota
JJJakub Jonakowski
Jakub Jonakowski
Background. Capsaicin-related compounds, including capsaicin, capsinoids/capsiate, dihydrocapsiate and phenylcapsaicin, are investigated as potential TRPV1-related ergogenic aids, but human exercise evidence remains heterogeneous. Objective. This structured narrative review summarizes human evidence on capsaicin-related compounds in resistance and high-intensity exercise, focusing on performance, rating of perceived exertion (RPE), fatigue, recovery, delayed-onset muscle soreness (DOMS), and selected physiological or neuromuscular outcomes. Methods. A structured PubMed search was supplemented by targeted compound-specific queries. After deduplication and search refinement, 62 unique records were screened by title and Human studies of oral supplementation in resistance, high-intensity, sprint, intermittent, CrossFit-type and recovery-related exercise contexts were prioritized. Findings. Current evidence suggests protocol-specific rather than universal ergogenic effects. Capsaicin showed selected benefits in small male crossover trials involving resistance exercise and high-intensity intermittent exercise, but not in repeated sprinting or continuous high-intensity running. Capsiate and dihydrocapsiate showed mixed findings, with no clear dose-response pattern. Phenylcapsaicin showed preliminary benefits for selected squat, jump, mechanical-performance and soreness-related outcomes, but not consistently for RPE, metabolic markers or whole-session CrossFit Workout-of-the-Day performance. Conclusions. Capsaicin-related compounds may have compound- and protocol-specific ergogenic potential, particularly in selected resistance and intermittent high-intensity settings. However, current evidence is limited by small samples, heterogeneous protocols, inconsistent outcomes and limited independent replication. Larger, well-controlled trials are needed before firm practical recommendations can be made.

28 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JJJakub Jonakowski
Jakub Jonakowski
JGJakub Grandos
Jakub Grandos
JNJulia Nowak
Julia Nowak
MŁMateusz Łaszczych
Mateusz Łaszczych
JWJulia Wykrota
Julia Wykrota
MPMateusz Polak
Mateusz Polak
Background. GLP-1 receptor agonists and related incretin-based therapies reduce appetite, energy intake, and body mass. Their growing use and discussion in sport raise concern about possible interactions with low energy availability, although a direct relationship with Relative Energy Deficiency in Sport (REDs) has not been established. Aim. To evaluate how GLP-1-based therapies may intersect with REDs-relevant pathways in physically active individuals while separating established clinical effects, athlete evidence, and untested inference. Materials and Methods. A structured narrative review used three PubMed/MEDLINE search streams addressing GLP-1 therapies and sport, appetite/body composition/exercise pathways, and REDs or low energy availability. Fifty-five full texts were assessed and the evidence was synthesized thematically. Results. Trials conducted mainly in non-athletic populations show reduced hunger, cravings, and laboratory-measured intake; gastrointestinal effects may further limit food tolerance. Weight loss includes variable reductions in lean-mass indices, but these measures do not establish loss of contractile muscle, strength, or performance. Athlete studies separately associate problematic low energy availability with reproductive, bone, endocrine, injury, and selected performance outcomes. No prospective study has tested progression from GLP-1 exposure to problematic low energy availability and REDs in athletes. Conclusions. GLP-1-based therapy should be considered a potential modifying factor within the REDs framework, not a proven cause. Current evidence supports individualized monitoring of treatment indication, weight trajectory, dietary adequacy, gastrointestinal tolerance, training, recovery, body composition, function, reproductive and bone health, and eating behavior. Athlete-specific prospective studies are required.

24 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
BBBarbara Bralewska
Barbara Bralewska
MPMateusz Polak
Mateusz Polak
JNJulia Nowak
Julia Nowak
MŁMateusz Łaszczych
Mateusz Łaszczych
JGJakub Grandos
Jakub Grandos
JWJulia Wykrota
Julia Wykrota
Background: Swimming-induced pulmonary edema (SIPE) is an uncommon but potentially serious complication of open-water swimming and triathlon. For event medical teams, the challenge extends beyond diagnosis to safe extraction, race-side assessment, respiratory support, and decisions about transfer or discharge.Objective: To review the clinical, physiological, and event-medicine literature on SIPE and develop a practical framework for medical care at mass-participation open-water events.Methods: We searched PubMed/MEDLINE and supplemented the search with Google Scholar, Semantic Scholar, Crossref, publisher websites, and citation tracking. Because the review was intended to inform event medicine, studies conducted in mass-participation settings were given greatest weight, with military, diving, physiological, and other clinical literature used when directly relevant.Results: Direct event evidence is concentrated in a small number of overlapping Vansbro cohorts. In symptomatic swimmers, pulse oximetry and auscultation performed well against LUS-confirmed pulmonary edema; at one low-altitude event, SpO₂ ≤95% or crackles gave 97% sensitivity and 86% specificity. These figures are specific to that setting. Lung ultrasound can add useful information, particularly because edema may be focal or anterior. CPAP and PEP have both been used on site with clinical improvement in observational data, but the available observational data do not establish comparative effectiveness. Crackles and B-lines may persist after symptoms and oxygenation improve. Severe, atypical, or non-resolving presentations require escalation.Conclusions: The literature supports a coherent sequence of event care: preparation, recognition, extraction, assessment, supportive treatment, reassessment, and a decision between escalation and stable disposition, followed by handover and follow-up. The framework proposed here is intended as a practical aid for local adaptation, not as a validated clinical protocol.